Hepatitis C testing and status among opioid substitution treatment clients in New South Wales

• 主要な著者: Fiona L. Shand (著者), Carolyn Day (著者), William Rawlinson (著者), Louisa Degenhardt (著者), Nicholas G. Martin (著者), Elliot C. Nelson (著者)
• フォーマット: 図書
• 出版事項: Elsevier, 2014-04-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Abstract Background: In Australia about half of the people who inject drugs (PWID) are hepatitis C (HCV) antibody positive (anti‐HCV+). The prevalence among opioid substitution treatment (OST) clients specifically is unclear, despite OST clinics being a potential setting for HCV care. This study aim...